State of Hypertension Management in the United States: Confluence of Risk Factors and the Prevalence of Resistant Hypertension

被引:89
|
作者
Sarafidis, Pantelis A. [2 ]
Bakris, George L. [1 ]
机构
[1] Univ Chicago, Pritzker Sch Med, Hypertens Dis Unit, Dept Med,Sect Endocrinol Diabet & Metab, Chicago, IL 60637 USA
[2] Aristotle Univ Thessaloniki, AHEPA Hosp, Dept Med 1, Sect Nephrol & Hypertens, Thessaloniki, Greece
来源
JOURNAL OF CLINICAL HYPERTENSION | 2008年 / 10卷 / 02期
关键词
D O I
10.1111/j.1751-7176.2008.07309.x
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
An improvement in the awareness and treatment of hypertension in the United States has occurred, resulting in the best control rates in the world, which unfortunately are far below the goals of Healthy People 2000 or 2010. This failure to achieve blood pressure (BP) goals is attributed to many factors, including an aging population, higher prevalence of kidney disease and obesity, high salt intake, physician inertia to increase dose and number of antihypertensive medications prescribed, and patient nonadherence with medication regimens. Resistant hypertension is defined as a failure to achieve goal BP in patients who adhere to full doses of an appropriate antihypertensive regimen of 3 drugs that includes a diuretic. The problem of resistant hypertension is projected to increase as the population ages. Efforts on the part of the Veterans Administration hospitals and others clearly indicate that a system can be implemented to help increase the percentage of persons in whom BP goal is achieved and reduce the prevalence of resistant hypertension. Medications specific to the problem of resistant hypertension are also under development. This review analyzes the status of hypertension control in the United States, the frequency of associated diseases, and adherence to guidelines; it further discusses strategies to reduce the prevalence of resistant hypertension. (J Clin Hypertens (Greenwich). 2008;10:130-139) (C) 2008 Le Jacq
引用
收藏
页码:130 / 139
页数:10
相关论文
共 50 条
  • [21] Pulmonary hypertension: prevalence and risk factors
    Faqih, Samia Ait
    Noto-Kadou-Kaza, Befa
    Abouamrane, Lalla Meryam
    Mtiou, Naoufal
    El Khayat, Selma
    Zamd, Mohamed
    Medkouri, Ghislaine
    Benghanem, Mohamed Gharbi
    Ramdani, Benyounes
    IJC HEART & VASCULATURE, 2016, 11 : 87 - 89
  • [22] Estimated prevalence of uncontrolled hypertension and multiple cardiovascular risk factors and their associated risk of coronary heart disease in the United States
    Benner, Joshua S.
    Smith, Timothy W.
    Petrilla, Allison A.
    Klingman, David
    Goel, Sangeeta
    Tang, Simon S. K.
    Wong, Nathan D.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2008, 2 (01) : 44 - 53
  • [23] Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States
    Kirson, Noam Y.
    Birnbaum, Howard G.
    Ivanova, Jasmina I.
    Waldman, Tracy
    Joish, Vijay
    Williamson, Todd
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (09) : 1763 - 1768
  • [24] Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China
    Sang, Xiaojing
    Jiang, Yiran
    Wang, Weiqing
    Yan, Li
    Zhao, Jiasheng
    Peng, Yongde
    Gu, Wei
    Chen, Gang
    Liu, Wei
    Ning, Guang
    JOURNAL OF HYPERTENSION, 2013, 31 (07) : 1465 - 1472
  • [25] Prevalence and Risk Factors of Noncontrolled and Resistant Arterial Hypertension in Renal Transplant Recipients
    Vetromile, Fernando
    Pernin, Vincent
    Szwarc, Ilan
    Garrigue, Valerie
    Delmas, Sylvie
    Mourad, Georges
    Fesler, Pierre
    TRANSPLANTATION, 2015, 99 (05) : 1016 - 1022
  • [26] Clustering of cardiovascular risk factors and metabolic syndrome prevalence in subjects with resistant hypertension
    Hernandez del Rey, Raquel
    Armario, Pedro
    Martin-Baranera, Montserrat
    Castellanos, Pere
    MEDICINA CLINICA, 2006, 127 (07): : 241 - 245
  • [27] Prevalence of Apparent Treatment-Resistant Hypertension in the United States: Comparison of the 2008 and 2018 American Heart Association Scientific Statements on Resistant Hypertension
    Carey, Robert M.
    Sakhuja, Swati
    Calhoun, David A.
    Whelton, Paul K.
    Muntner, Paul
    HYPERTENSION, 2019, 73 (02) : 424 - 431
  • [28] MANAGEMENT OF RESISTANT HYPERTENSION IN A RESISTANT HYPERTENSION UNIT
    Alegria-Barrero, E.
    Alonso-Viteri, S.
    Teijeiro-Mestre, R.
    Ruiz-Garcia, J.
    Besada, E.
    Franco, A. I.
    Blazquez, M. A.
    Vega, M.
    San Martin, M. A.
    CARDIOLOGY, 2015, 132 : 224 - 224
  • [29] Prevalence and predictors of cirrhosis and portal hypertension in the United States
    Younossi, Zobair M.
    de Avila, Leyla
    Racila, Andrei
    Nader, Fatema
    Paik, James
    Henry, Linda
    Stepanova, Maria
    HEPATOLOGY, 2025,
  • [30] Management of resistant hypertension in patients with carotid stenosis: High prevalence of renovascular hypertension
    Spence, JD
    CEREBROVASCULAR DISEASES, 2000, 10 (04) : 249 - 254